Expression of erythropoietin in the spinal cord of lewis rats with experimental autoimmune encephalomyelitis

Journal of Clinical Neurology (Korea)

Volumn 5, Issue 1, 2009, Pages 39-45

  Kang, Sa Yoon ^a   Kang, Ji Hoon ^a   Choi, Jay Chol ^a   Lee, Jung Seok ^a   Lee, Chang Sub ^b   Shin, Taekyun ^c  

^a Departments of Neurology   (South Korea)

^b Departments of Neurosurgery   (South Korea)

^c Jeju National University School of Medicine   (South Korea)

Author keywords

Aaastrocytes; Erythropoietin; Experimental autoimmune encephalomyelitis; Macro phages

Indexed keywords

EID: 77952110250     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2009.5.1.39     Document Type: Article

References (21)

1. Sirén AL, Ehrenreich H. Erythropoietin--a novel concept for neu-roprotection. Eur Arch Psychiatry Clin Neurosci 2001;251:179-184.
2. Buemi M, Cavallaro E, Floccari F, Sturiale A, Aloisi C, Trimarchi M, et al. The pleiotropic effects of erythropoietin in the central nervous system. J Neuropathol Exp Neurol 2003;62:228-236.
3. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 2005;6:484-494.
4. Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol 2004; 207:3233-3242.
5. Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 2001;21:9733-9743.
6. Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, et al. Erythropoietin receptor signaling is required for normal brain development. Development 2002;129:505-516.
7. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 2000;97:10526-10531.
8. Chung YH, Kim SI, Joo KM, Kim YS, Lee WB, Yun KW, et al. Age-related changes in erythropoietin immunoreactivity in the cerebral cortex and hippocampus of rats. Brain Res 2004;1018:141-146.
9. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004;35:1732-1737.
10. Chung YH, Joo KM, Kim YS, Lee KH, Lee WB, Cha CI. Enhanced expression of erythropoietin in the central nervous system of SOD1 (G93A) transgenic mice. Brain Res 2004;1016:272-280.
11. Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, et al. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 2002;952:128-134.
12. Zhang J, Li Y, Cui Y, Chen J, Lu M, Elias SB, et al. Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res 2005;1034;34-39.
13. Li W, Maeda Y, Yuan RR, Elkabes S, Cook S, Dowling P. Beneficial effect of erythropoietin on experimental allergic encephalomyelitis. Ann Neurol 2004;56:767-777.
14. Savino C, Pedotti R, Baggi F, Ubiali F, Gallo B, Nava S, et al. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J Neu-roimmunol 2006;172:27-37.
15. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002;22:10291-10301.
16. Sirén AL, Knerlich F, Poser W, Gleiter CH, Brück W, Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 2001;101:271-276.
17. Rotshenker S. Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease. J Mol Neurosci 2003;21:65-72.
18. Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 2000;20:5283-5291.
19. Trzonkowski P, Debska-Slizien A, Szmit E, Myśliwska J, Szymahska K, HakŁ, et al. Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients. Nephrol Dial Transplant 2005;20:367-376.
20. Shin T, Kojima T, Tanuma N, Ishihara Y, Matsumoto Y. The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J Neu-roimmunol 1995;56:171-178.
21. Moon C, Kim S, Wie M, Kim H, Cheong J, Park J, et al. Increased expression of p53 and Bax in the spinal cords of rats with experimental autoimmune encephalomyelitis. Neurosci Lett 2000;289:41-44.